4 completed, 1 not yet recruiting. 2 Not applicable, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Not yet recruiting 1 |
| Phase 3 | 2 | Completed 2 |
Follow Spasticity, Post-Stroke: new trials by email Literature Review of Spasticity, Post-Stroke trials Research Report on Spasticity, Post-Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extracorporeal Shock Wave Therapy in Botulinum Toxin-Treated Patients With Post-Stroke Ankle Plantar Flexor Spasticity Radial Extracorporeal Shock Wave Therapy (rESWT), Conventional Physical Therapy and Rehabilitation - Stroke, Post-stroke Spasticity of the Lower Limb | Not applicable | Not yet recruiting | Pamukkale University | 32 | 2026-07-20 | 2026-07-10 |
| The Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Stroke Patients Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation Sham - Spasticity, Post-Stroke | Not applicable | Completed | Ankara City Hospital Bilkent | 20 | 2021-07-01 | 2025-03-21 |
| A Phase III Study to Evaluate the Efficacy and Safety of GSK1358820 in Subjects With Post-stroke Upper Limb Spasticity Botulinum toxin A (GSK1358820), Placebo - Spasticity, Post-Stroke | Phase 3 | Completed | GlaxoSmithKline | 124 | 2017-08-02 | 2020-06-02 |
| A Multicenter, Open-label, Single Dose Study of the Safety and Efficacy of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Focal Upper Limb Spasticity Botulinum toxin type A - Spasticity, Post-Stroke | Phase 3 | Completed | GlaxoSmithKline | 109 | 2010-09-01 | 2017-02-28 |
| JCP Study of Investigation of Patient Background Characteristics BOTOX - Spasticity, Post-Stroke | Completed | GlaxoSmithKline | 326 | 2010-05-01 | 2017-06-07 |
Muscle Spasticity (5) · Stroke (1)
Muscle Hypertonia (5) · Muscular Diseases (5) · Musculoskeletal Diseases (5) · Nervous System Diseases (5) · Neurologic Manifestations (5) · Neuromuscular Manifestations (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Vascular Diseases (1)
Botulinum Toxins, Type A (3) · Rehabilitation (1) · Transcranial Magnetic Stimulation (1)
GlaxoSmithKline (3) · Ankara City Hospital Bilkent (1) · Pamukkale University (1)
Turkey (Türkiye) (2) · China (1) · Japan (1)